BioSig Technologies, Inc.

12424 Wilshire Blvd., Suite 745

Los Angeles, California 90025


March 28, 2019




U.S. Securities and Exchange Commission

Division of Corporation Finance
Securities and Exchange Commission
Washington, D.C. 20549

Attention: Michael Fay



BioSig Technologies, Inc.
Registration Statement on Form S-3, filed on March 22, 2019

File No. 333- 230448 (the “Registration Statement”)

Request for Acceleration


Ladies and Gentlemen:


Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioSig Technologies, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 5:00 p.m., Eastern Time, on March 29, 2019, or as soon thereafter as practicable.



  Very truly yours,
  By:  /s/ Steve Chaussy
    Steve Chaussy
Chief Financial Officer



cc:    Rick A. Werner, Esq., Haynes and Boone, LLP